Detecting ongoing disease activity in mildly affected multiple sclerosis patients under first-line therapies
Lars Masanneck(Heinrich Heine University Düsseldorf), Marc Pawlitzki(Heinrich Heine University Düsseldorf), Liesa Regner-Nelke(Heinrich Heine University Düsseldorf), Saskia Räuber(Düsseldorf University Hospital), Stefan Bittner(Johannes Gutenberg University Mainz), Tobias Ruck(BG University Hospital Bergmannsheil Bochum), Falk Steffen(Johannes Gutenberg University Mainz), Hans‐Peter Hartung(The University of Sydney), Alice Willison(Düsseldorf University Hospital), Frauke Zipp(Johannes Gutenberg University Mainz), Philipp Albrecht(Universitäts-Herzzentrum Freiburg-Bad Krozingen), Leoni Rolfes(University Hospital Münster), Sven G. Meuth(University Hospital Münster)
Cited by 21
Related Papers
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k